Aims & Scope

Frontiers in Bioscience-Elite (Elite) focuses on high quality research articles and review papers in biotechnology and applied microbiology that are of relevance to the biological, biomedical, agricultural and environmental science communities. The journal encompasses all aspects of biotechnology and applied microbiology in areas such as omics, genome editing, gene therapy, transgenics, bioprocessing, therapeutics, and agro-environment.

Publishing data in scientific journals is the principal means for disseminating information important to other investigators and the public. Publications are also important to investigators since as they reflect the extent of their scholarly activities, are an important component in promotion, and are necessary to obtain grant support.

Therefore, Elite considers all publications as important communications, and all efforts will be made to post the manuscript online in as minimal amount of time as possible after acceptance for publication. Elite strives to assist science industries to deliver the mission of their business to thousands of scientists and decision-makers around the globe.

Subject Terms:

Genomics; Regenerative medicine; Pharmaceuticals; Drug delivery; Transcriptomics; Molecular therapy; Proteomics; Environmental biotechnology; Bionanotechnology; Biomaterials; Food; Agriculture; Plants; Biofuels; Synthetic biology; Biocatalysis; Bioremediation; Biochemical engineering; Applied enzymology; Industrial biotechnology; Metabolic engineering; Genome editing; Single-cell technologies; Bioinformatics; Diagnostics; Biosensors; Biofabrication; Stem cells; Tissue Engineering; Antibodies; Environmental engineering; Genetically modified crops; Molecular engineering; Nucleic acids; Proteins; Functional genomics; Structural genomics; Metabolomics; Computational biology; Imaging technology; Analytical biotechnology; Applied immunology; Antibody engineering; Xenotransplantation; T-cell therapies; Process engineering; Genetic engineering; Chemogenomics; Chemical genetics; Pharmacogenomics; Computational analysis; Mammalian cells; Insect cells; Bacteria; Fungi; Plant cells; Nucleic acid therapeutics; Gene therapy; Vaccines; Antibody engineering; Therapeutic cloning; Assay systems; Microfluidics;Biomimetics; Molecular imprinting; Agbiotech; Transgenic plants; Crop improvement; Nutraceuticals; Forest biotechnology; Plant vaccines; Pharming; Transgenic animals; Reproductive cloning; Biomining; Phytoremediation; Monitoring; etc.

Elite is published 2 issues per year, and follows the guidelines of the Committee on Publication Ethics (COPE) and the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).